Predicting response to iron supplementation in patients with active inflammatory bowel disease (PRIme): a randomised trial protocol.

Roberta LoveikyteMarjolijn DuijvesteinZlatan MujagicRogier L GoetgebuerGerard DijkstraAndrea E van der Meulen-de Jong

Published in: BMJ open (2024)

Prospectively registered in the https://clinicaltrials.gov/ and the Eudra registries. First submitted on 10 May 2022 to the ClinicalTrials.gov (ID: NCT05456932) and on 3 March 2022 to the European Union Drug Regulating Authorities Clinical Trials Database (ID: 2022-000894-16).

Keyphrases

clinical trial
adverse drug
open label
study protocol
randomized controlled trial
phase ii
iron deficiency
ulcerative colitis
emergency department
drug induced
electronic health record
placebo controlled